Skip to main content

Table 2 Diagnostic Accuracies for ECE Using mpMRI, 68 Ga-PSMA-11 PET/CT and MRI + PET/CT compared to Final Histology

From: Prediction of T staging in PI-RADS 4–5 prostate cancer by combination of multiparametric MRI and 68Ga-PSMA-11 PET/CT

 

mpMRI

68 Ga-PSMA-11 PET/CT

mpMRI + PET/CT

PI-RADS 1–5

 AUC (95%CI)

0.69 (0.58–0.79)*

0.74 (0.64–0.84)

0.79 (0.70–0.88)*

 Youden-selected threshold

3

4

5

 Sensitivity, %, at threshold (95%CI)

40 (28–54)*

54 (40–67)†

66 (52–78) *†

Specificity, %, at threshold (95%CI)

94 (85–98)

89 (77–95)

85 (73–92)

ECE

Positive

20

27

33

Negative

30

23

17

None-ECE

Positive

3

6

8

Negative

50

47

45

PI-RADS 1–3

 AUC (95%CI)

0.60 (0.41–0.78)

0.56 (0.38–0.74)

0.62 (0.47–0.79)

 Youden-selected threshold

3

3

3

 Sensitivity, %, at threshold (95%CI)

28 (12–55)

57 (32–79)

92 (68–100)

 Specificity, %, at threshold (95%CI)

91 (78–97)

54 (38–70)

40 (26–56)

ECE

Positive

4

6

13

Negative

10

8

1

None-ECE

Positive

3

12

21

Negative

32

23

14

PI-RADS 4–5

 AUC (95%CI)

0.70 (0.57–0.84)*

0.85 (0.75–0.95)

0.88 (0.79–0.98)*

 Youden-selected threshold

3

4

5

 Sensitivity, %, at threshold (95%CI)

44 (30–60)*

66 (50–80)

80 (65–90)*

 Specificity, %, at threshold (95%CI)

100 (82–100)

100 (82–100)

100 (82–100)

ECE

Positive

16

24

29

Negative

20

12

7

None-ECE

Positive

0

0

0

Negative

18

18

18

  1. PI-RADS Prostate Imaging Reporting and Data System, AUC area under the curve, CI confidence interval, mpMRI multiparametric magnetic resonance imaging, PET/CT positron emission tomography computed tomography, ECE extracapsular extension, mpMRI + PET/CT combination of 68 Ga-PSMA-11 PET/CT and mpMRI
  2. * mpMRI versus mpMRI + PET/CT, p < 0.05
  3. PET/CT versus mpMRI + PET/CT, p < 0.05